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Abstract
The recent detection and isolation of C. ureolyticus from patients with diarrhoeal illness and inflammatory bowel diseases
warrants further investigation into its role as an emerging pathogen of the human gastrointestinal tract. Regarding the
pathogenic mechanisms employed by this species we provide the first whole genome analysis of two C. ureolyticus isolates
including the type strain. Comparative analysis, subtractive hybridisation and gene ontology searches against other
Campylobacter species identifies the high degree of heterogenicity between C. ureolyticus isolates, in addition to the
identification of 106 putative virulence associated factors, 52 of which are predicted to be secreted. Such factors encompass
each of the known virulence tactics of pathogenic Campylobacter spp. including adhesion and colonisation (CadF, PEB1,
IcmF and FlpA), invasion (ciaB and 16 virB-virD4 genes) and toxin production (S-layer RTX and ZOT). Herein, we provide the
first virulence catalogue for C. ureolyticus, the components of which theoretically provide this emerging species with
sufficient arsenal to establish pathology.
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Introduction
Within the last decade a growing number of atypical
Campylobacter species have been reported as emerging human
pathogens [1]. Traditionally, C. jejuni and C. coli have been the
main species associated with human illness, however advances in
molecular diagnostics coupled with the development of novel
culture techniques have facilitated the detection and isolation of a
range of under reported and highly fastidious Campylobacter species
[2,3], including C. concisus and more recently C. ureolyticus [4,5].
C. ureolyticus (previously Bacteroides ureolyticus) has only recently
been classified within the Campylobacter genus [6]. Although in
1991, Vandamme et al. proposed that B. ureolyticus be reclassified
as a member of the Campylobacter genus [7], its fatty acid profile and
hydrolysis of gelatin and casein differentiated this organism from
other Campylobacter species and B. ureolyticus remained as ‘species
incertae sedis’[6,8,9]. Almost two decades later, employing a
polypahsic approach, Vandamme and colleagues reported that
B. ureolyticus shared (i) respiratory quinone content, (ii) DNA base
ratio, and (iii) phenotypic characteristics with Campylobacter species,
including Campylobacter jejuni and resulted in the reclassification of
Bacteroides ureolyticus as Campylobacter ureolyticus [6].
Historically, C. ureolyticus has been associated with a range of
diseases, including superficial ulcers, gangrenous lesions, nongon-
ococcal urethritis, bacterial vaginosis, and of late, male infertility
[6,10,11,12]. Furthermore, analogous to several other emerging
and atypical Campylobacter species, C. ureolyticus has been linked with
periodontal lesions, including gingivitis and peridontitis [2,13,14].
Recent work has led to the detection and subsequent isolation of
C. ureolyticus as the sole pathogen from faecal samples of diarrheic
patients [4,15,16]. Using a species specific PCR (targeting the
hsp60 gene), C. ureolyticus is now believed to be the second most
common Campylobacter species detected in diarrhoeic patients
surpassing the established pathogen C. coli and exceeded only by C.
jejuni [13]. Additionally, analysis of infectivity data reveals a
predominance of C. ureolyticus in patients at extremes of age (,5
years and .70 years) suggesting an opportunistic nature for the
pathogen [17]. Furthermore, we have noted a seasonal prevalence
and have identified potential reservoirs of infection [18].
Following our initial report, C. ureolyticus has been detected at
significantly higher rates in patients with Ulcerative Colitis (21.7%)
in comparison to healthy controls (3.1%) [19]. In support of this, a
New South Wales study [20], report the detection and isolation of
C. ureolyticus from biopsy specimens and faecal samples from
children with newly diagnosed Crohn’s disease (CD). This group
later report on the pathogenic potential of C. ureolyticus: observing
that their strain C. ureolyticus UNSWCD was capable of colonizing
and adhering to intestinal cells - resulting in cellular damage and
microvillus degradation [21]. As such, the recent emergence of C.
ureolyticus in patients with gastrointestinal illness, at higher levels
than the healthy controls, provides a compelling case that C.
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ureolyticus is likely to be an emerging gastrointestinal pathogen of
some importance.
Despite the growing evidence to suggest that non-C. jejuni/C. coli
species are significant contributors to human disease [2,15,22], our
existing understanding of Campylobacter pathogenesis is essentially
restricted to C. jejuni. Furthermore, the literature regarding the
mechanisms of C. jejuni invasion is highly controversial, whereby
some groups report the paracellular route and others described the
transcellular model or a mix of both [23,24,25,26,27]. In general,
the past decade has provided us with substantial findings, revealing
many of the virulence components of C. jejuni [28], however the
exact mechanism of its pathology is as yet still unclear [29,30]. The
small, curved shape of this Gram-negative bacterium, coupled
with flagella-mediated motility, allow C. jejuni to penetrate
intestinal mucus [31], where it can then adhere to epithelial cells
via various surface associated adhesions, such as CadF and FlpA,
which mediate binding to host tissue fibronectin [32]. Once
attached, the bacterium then employs a range of secretion systems
including the flagellar type III, the type IV and the recently
identified type VI [33,34,35,36], through which it secretes invasion
antigens, such as CiaB, which may promote cellular invasion of the
intestinal epithelial cells [37] . Furthermore, C. jejuni produces
various toxins including CdtA-C, which have been reported to
promote cellular cytotoxicity and apoptotic cell death [31].
More recently, whole genome investigation followed by in vitro
analysis of the emerging gastrointestinal pathogen C. concisus
revealed potential components contributing to the organism’s
pathogenesis; including several toxins, invasins in addition to
colonisation, and adhesion factors [5,31,38,39]. Studies by Man et
al. [26] report that in addition to a transcellular route of invasion,
C. concisus UNSWCD preferentially attaches to intercellular
junctional spaces facilitating translocation across the epithelium,
thus promoting a paracellular route of invasion [20,40].
A likely reason for our current lack of knowledge regarding
pathogenic mechanisms of C. ureolyticus is the lack of genomic data:
until now the potential virulence apparatus of C. ureolyticus has
remained unknown. Herein, we provide the first whole genome
analysis of two C. ureolyticus strains. A comparative bioinformatics
based approach was performed to identify putative virulence
factors, secreted proteins and genomic heterogeneity of the two C.
ureolyticus isolates in an investigation of the pathogenic mechanisms
of this emerging pathogen.
Materials and Methods
Strains used in this study
The C. ureolyticus strains used in this study are outlined in
Table 1.
Genome assembly
Sequence data for Campylobacter ureolyticus ACS-301-V-Sch3b
were obtained from the Sequence Read archive (SRA), having
been collected by the Broad institute as part of the Human
Microbiome Project for use as a reference genome for the
Campylobacter ureolyticus species, but which had yet to be assembled.
The sample was isolated from the female vaginal tract and had
been sequenced using Illumina HiSeq with 100 bp pair end reads.
The accession number to the SRA raw data is SRX115248.
C. ureolyticus has not been previously sequenced so no reference
genome is currently available for assembly. Additionally, Campylo-
bacter strains of the same species have previously been shown to
display large variation within the overall gene content of their
genomes whereby distinct genomospecies have been identified,
thought to be mainly attributable to horizontal gene transfer and
gene loss. For strains with genomes divergent from their closest
references or in the absence of a reference genome, reference-
sequence guided assembly methods can provide limited genome
definition; therefore a de novo assembly method was used.
The Velvet assembly tool [41] was used due to its compatibility
with Illumina data and having been shown to be one of the best
performing assembly programs available for paired end data [42].
Using Velvet a range of k-mer values from 39 to 59 (which
determine the minimum read overlap) was tested to find the
optimum hash length for assembly of the data. Velvet is based on a
directed graph representation called de Bruijn graphs which uses
non-redundant sets of k-mers or word length rather than sequence
reads as its primary data structures. For the paired end reads a k-
mer value of 53 was seen to be the optimal hash length. This
information was subsequently used to carry out the assembly using
Velvet, giving an N50 of 60,555 and a maximum contig length of
227,136 bp with a total of 115 contigs and a genome size of
1659961 bp, having removed contigs with a length of less than
100 bp.
(Note: The Accession Number to access C. ureolyticus DSM
20703 scaffolds is KB894730–KB894764 The location of the C.
ureolyticus ACS-301-V-Sch3b scaffolds is: https://olive.
broadinstitute.org/genomes/camp_ureo_acs-301-v-sch3b.1)
Table 1. Strains used in this study.
Strain Gender Age (Years) Sample Source Medical Summary/Additional Information
Availability of
whole genomic data
CIT001 Male 83 Faeces Long stay psychiatry unit In process (Our group)
CIT002 Female 84 Faeces End stage chronic renal disease In process (Our group)
CIT004 Female 3 Faeces Admitted to hospital overnight with D/V and fever. Had
Cryptosporidium oocysts
In process (Our group)
CIT005 Female 3 Faeces D/V. Had Cryptosporiium oocysts In process (Our group)
CIT007 Female 84 Faeces End stage chronic renal disease In process (Our group)
CIT009 Female 83 Faeces Nursing home resident In process (Our group)
DSM 20703 Female Unknown Amniotic Fluid Type Strain; originally isolated in 1978 Assembled
ACS-301-Sch-V-3b Female Unknown Vagina A reference genome for the Broad Institute as part of
the ‘The Human Microbiome Project’
Assembled
doi:10.1371/journal.pone.0071515.t001
Campylobacter ureolyticus Virulence Potential
PLOS ONE | www.plosone.org 2 August 2013 | Volume 8 | Issue 8 | e71515
Degree of diversity within Campylobacter ureolyticus
In addition to using the comparative genomics modules in
RAST [43] and IMG/ER [44], we also conducted customized
homology searches using BLAST (blastp, tblastn) and STRING to
determine probable orthologs of genes conserved between the two
C. ureolyticus strains and other species within the Campylobacter
genus.
Bidirectional homology searches were performed on the two C.
ureolyticus strains whereby cut off values set at 25% amino acid
identity plus a minimum of 85% coverage were employed to
identify the percentage of unique protein between both C.
ureolyticus strains. A cut off a maximum 25% identity was employed
to exclude homologues. The results obtained were compared with
that of searches between the validated genomes of 4 C. jejuni strains
within the RAST database; C. jejuni NCTC 11168, C. jejuni
RM1221, C. jejuni 260.94 and C. jejuni 81-176. Cut-off values of
70% identity with a minimum of 85% gene length coverage were
employed. A cut off value of a minimum of 70% identity was
employed to identify highly conserved genes. It is important to
note that in this study we considered protein sequences with
.25% identity to be homologous, however those with .70%
identity we conserved them to be highly conserved. Using the
same parameters with C. jejuni NCTC 11168 set as the reference
genome and 3 C. jejuni strains RM1221, 260.94 and 81-176 were
individually and jointly compared to determine degree of identity
at the amino acid level.
Furthermore, to identify the protein coding genes that are
conserved between Campylobacter species, the genome of both C.
ureolyticus strains DSM 20703 and ACS-301-Sch-V-3b were each
set as reference genomes and compared to the protein coding
genes within the genomes of all the available Campylobacter species
in the RAST database; C. jejuni NCTC 11168, C. jejuni subsp. doylei
strain 269.97, C. coli RM2228 [B], C. lari RM2100, C. upsaliensis
RM3195, C. fetus subsp. fetus 82-40, C. curvus 525.92, C. concisus
13826 and C. hominis ATCC BAA-381. The minimum cut off limit
for highly conserved genes was set to 70% amino acid identity
using the RAST sequence based comparison tool. To identify
genes unique to C. ureolyticus (ie: no homologues in the other
Campylobacter species analysed) the maximum cut off identity value
was set to 25% for the Campylobacter species mentioned above,
additionally C. ureolyticus ACS-301-Sch-3b was included as a
comparison genome where by the cut off identity value was set at a
minimum of 70%. This allows for the identification of proteins
conserved across the two C. ureolyticus strains but absent in other
Campylobacter species.
Gene prediction, identifying orthologs and synthenic
associations
C. ureolyticus strains DSMZ 20703 (type strain) and ACS-301-V-
Sch3b isolated from the female vaginal tract are the first
Campylobacter ureolyticus strains to have been sequenced.
The C. ureolyticus DSMZ 20703 genome (IMG submission ID
11117, NCBI project ID 174981) and fasta sequences for 1799
protein coding genes were downloaded from the IMG/ER
website. The RAST [43] web application server was used for
gene predictions using the Glimmer3 [45] program.
Furthermore, functional domain analysis was conducted with
Pfam and the Kyoto Encyclopedia of Genes and Genomes,
available at (http://www.genome. jp/kegg) [46], was employed to
determine the biochemical pathways to which genes were
assigned.
The Search Tool for the Retrieval of Interacting Proteins
(STRING), a database of known and predicted protein–protein
interactions available at http://string.embl.de/, was employed to
examine functional relationship between proteins across multiple
species [47].
BlastP (NCBI database) and Atlas T4SS (http://www.t4ss.lncc.
br/) were employed to identify similarity between the type IV
secretion systems within in C. ureolyticus ACS-301-V-Sch3b to other
organisms. Atlas T4SS is a database describing a large number of
proteins related to the type IV secretion system reported in both
Gram-negative and Gram-positive bacteria, as well as in Archaea.
Comparative bioinformatic analyses
Homology searches were performed using the blastp and blastn
tools through the National Centre for Biotechnology Information
(NCBI) website (available at http://www.ncbi.nlm.nih.gov/) using
the default settings. Comparative bioinformatic analyses on the
genomes of C. ureolyticus strains DSM 20703 and ACS-301-V-
Sch3b were performed using the RAST database. Both functional
and sequence based analysis were performed using default settings.
Secretome Prediction
The presence and location of signal peptide cleavage sites in the
amino acid sequences were predicted using the default settings for
Gram-negative bacteria on the SignalP Server 4.1 [48] (http://
www.cbs.dtu.dk/services/SignalP/). Non-classically secreted pro-
teins were predicted using the SecretomeP 2.0 Server [49] (http://
www.cbs.dtu.dk/services/ SecretomeP/). SecretomeP predicts the
possible secretion of proteins following signal peptide independent
secretion pathways.
The statistical cut off was the default setting for both SignalP4.1
and the SecretomeP2.0 servers.
As a comparison, using identical parameters set for the C.
ureolyticus analysis, the total percentage of C. jejuni NCTC 11168
secreted proteins were predicted using both the SignalP4.1 and
SecretomeP2.0 servers. The amino acid sequences of C. jejuni
NCTC 11168 protein coding genes were extracted from the
IMG/ER annotation pipeliner server.
Culturing of bacterial strains
C. ureolyticus strains were inoculated on to blood agar plates
(Columbia Blood Agar base; Sigma Aldrich, with 5–7% defibrin-
ated horse blood; Thermoscientific) supplemented with 2.5 g/L of
Sodium Formate (Sigma Aldrich), 2.5 g/L Sodium Fumarate
(Sigma-Aldrich) and 20 mg/mL of vancomycin (Sigma-Aldrich)
[6]. The strains were grown under anaerobic conditions (Anaero-
Gen Gas Generating Systems Oxoid) at 37uC for 48 hours. The
identity of the cultures were confirmed by) the presence of flat,
spreading colonies on the blood agar plates, positive urea slants
(Christensen’s Urea Agar, Sigma-Aldrich) and the presence of
slender Gram-negative rods under a light microscopy.
Validations of syntenic associations
Bacterial DNA was extracted using the QIAamp DNA Mini Kit
(Qiagen, Manchester, UK) according to the manufacturer’s
instructions. The concentration and quality of DNA was measured
using a Nanodrop ND-1000 Spectophotometer (Nanodrop
Technologies, Fischer Scientific,Ireland). To conifirm the presence
of C. ureolyticus DNA in the samples following DNA extraction, C.
ureolyticus specific PCR targeting the hsp60 gene was conducted as
described by Bullman et al. [4]. The confirmation of the presence/
absence of gene that were shown to be present in C. ureolyticus DSM
20703 but absent in ACS-301-V-Sch3b by next-generation
sequencing was performed on the DSM 20703 strain along with
6 C. ureolyticus clinical isolates using PCR.
Campylobacter ureolyticus Virulence Potential
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Primer pairs were designed to amplify regions (2,861, 1,625,
1,469, 311 bp) within several ORF clusters found in either DSMZ
20703 or ACS-301-V-Sch3b (Table 2). All PCR amplifications
were performed in a 50 ml reaction volume, containing 3 ml DNA
template, 1 U HotStarTaq DNA Polymerase (QIAGEN, West
Sussex, UK; 203205); 5 ml of 106 PCR buffer and 1 ml 25 mM
MgCl2 (provided with HotStarTaq DNA Polymerase), 8 ml of
dNTPs mixture (1.25 mM of each dNTP; Sigma-Aldrich Ireland
Ltd. Arklow, Ireland), and 2 ml of each primer (25 pmol/ml;
Eurofins MWG Operon, London, UK), 29 ul molecular grade
water. The thermal cycling conditions for all 4 reactions were:
94uC for 5 min, 35 cycles of 94uC for 30 s, Annealing temperature
as specified in Table 1 for 30 s, and 72uC for 1 min per kb to be
amplified, followed by 72uC for 5 min. PCR products were
electrophoresed through 1.5% agarose gels at 100 V for 40–
60 min. The products were then purified using the QIAquickH
PCR Purification Kit (Qiagen, Manchester, UK) according to
manufacturer’s instructions. PCR positive products were se-
quenced by MWG (Eurofins, Germany) and analysed by Clustal
W [50].
Expression of these genes under standard conditions (as
described previously) was investigated by reverse transcriptase
PCR (rt-PCR). Briefly total RNA was extracted by Roche high
pure RNA extraction kit (Roche Diagnostics, Mannheim,
Germany) as per the manufacturer’s guidelines and the purity
and concentration of the RNA was measured using a Nanodrop
ND-1000 Spectophotometer (Nanodrop Technologies). The RNA
extracted was normalised across all strains and cDNA was
synthesised using Tetro cDNA synthesis kit (Bioline). Gene specific
PCR was carried out on both RNA and cDNA to ensure absence
of contaminating genomic DNA.
SDS-PAGE
Campylobacter ureolyticus strains were grown on blood agar plates
(as described previously), bacterial cells were harvested and
washed twice in phosphate buffered saline (PBS). Soluble proteins
were extracted from the packed cells using B-PER Protein
Extraction Reagents (Thermo Scientific) as per manufacturer’s
guidelines. The B-PER Protein extraction reagent is a nonionic
detergent that disrupts cells and solubilizes native proteins without
denaturation. Soluble protein was quantified by the bicinchoninic
acid method (Pierce) [51], using bovine serum albumin as the
standard. Proteins were separated according to their electropho-
retic mobility in a sodium dodecyl sulphate polyacrylamide gel
(SDS-PAGE), as described by Laemmli et al., [52]. Proteins were
resolved on 12% (w/v) resolving and 5% (w/v) stacking
acrylamide gels. Gels were stained using Coomassie Brilliant Blue
G-250 (Bio-Rad). Phoretix 1D pro software (TotalLab Ltd.;
Newcastle Upon Tyne, NE, UK) was employed to analyse the
percentage similarities between the protein profiles of the two C.
ureolyticus strains, and to cluster the lanes based on banding
patterns.
Results and Discussion
Confirmation of bacterial pathogenesis and virulence potential
requires a multi-factorial approach encompassing epidemiological
data, candidate gene identification and functional analysis. The
recent deposition of two C. ureolyticus genome sequences (strains
DSM 20703 and ACS-301-V-Sch3b) has for the first time
facilitated the genetic analysis of the pathogenic potential of this
species. The type strain DSM 20703, originally isolated in 1978
from human amniotic fluid [9], was sequenced as part of ‘The one
thousand microbial genomes (KMG)’ project. Strain ACS-301-V-
Sch3b was isolated from the human vaginal cavity and sequenced
by the Broad Institute as a reference genome for ‘The Human
Microbiome Project’.
Campylobacter ureolyticus diversity
The complex taxonomy of typical and emerging Campylobacter
species is well established [53], whereby certain isolates, although
conforming to the phenotypic description of a particular species,
may exhibit a large degree of heterogeneity at the genomic level
[54,55]. For instance the emerging pathogen C. concisus is
composed of several genemospecies that are likely to have varying
impacts on human health and disease [31,39,56].
In the current study, bidirectional homology searches between
the type strain DSMZ 20703 and the vaginal isolate ACS-301-V-
Sch3b revealed that 75–79.5% of proteins were highly conserved
(70% identity). Using the same parameters with C. jejuni NCTC
11168 set as the reference genome, individual and multiple
comparisons to 3 other C. jejuni strains, revealed that 92% and
87% of proteins respectively are highly conserved. Such data
suggest that substantial variation exists within these two C.
ureolyticus genomes. Interestingly, average percentage identities
for all homologs revealed that C. ureolyticus strains had a higher
variation when compared to the phylogenetically related species C.
jejuni (94 vs. 98%, respectively).
Futhermore, whole genome comparison of the protein coding
genes of the two C. ureolyticus strains against other members of the
Campylobacter genus revealed that 9–22% of proteins were highly
conserved across different Campylobacter species (Table 3). The
greatest number of highly conserved homologs were present in C.
hominis followed by C. consisus then C. curvus and C. fetus subsp. fetus.
Table 2. Primers used in this study.
Target Primer Sequence 59 – 39 Annealing (6C) Product (bp) Source
rtx 71RTX F CCT TAG CTC TTT TAT CAA GCG ATG 58 2,861 This study
2932RTX R CAC TCT TAT CGA TTG TAA TAA AGC C This study
virD4 262VirD4*F GAA ATG CAA GAT TTG CAA ACT CAG C 57 1,625 This study
1887VirD4*R CTC AGC ATC TTC TTC TAT TGG C This study
ciaB 266CiaB F TAC ATG AAA ACT CTC ATA GAA ATT TAA TC 56 1,469 This study
1735 CiaB R AGT AGT AGA TAA CAA ACT CTT TTG CAT C This study
doc 32Doc1 F GTT TGC ATG ATG ATA TAA TGG ATG 54 311 This study
343Doc1R TGA GTT AAA TCA TCT TTT GTT ATC TC This study
doi:10.1371/journal.pone.0071515.t002
Campylobacter ureolyticus Virulence Potential
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There are approximately 128 protein coding genes that were
determined to be highly conserved across all Campylobacter species
test when using C. ureolyticus DSM 20703 as the reference genome.
These proteins have functions ranging from stress response,
membrane transport, respiration and the metabolism of macro-
molecules (Table S1).
On the other hand C. upsaliensis RM3195 and C. lari RM2100
shared the lowest percentage of highly conserved protein coding
genes and up to 40% of C. ureolyticus proteins did not contain
homologs within the genomes of these species (Table 3). A total of
65 proteins were highly conserved between the two Campylobacter
species (.70% identity) yet had no homologs (,25% identity) in
any of the other Campylobacter species tested (Table S2). The
majority of these proteins (n = 45) were classed as hypothetical and
miscellaneous (n = 9). Additionally, the urease operon was also
presented within this group (Table S2); however it is important to
note that C. sputorum biovar. paraureolyticus and subset of C. lari
UPTC (urease positive thermophilic Campylobacter) also contain this
operon [57,58]. As the whole genomes of these species are
currently unavailable, they were not included in the comparison
analysis.
While the genomes of C. ureolyticus DSMZ 20703 (1.74-Mb) and
ACS-301-V-Sch3b (1.66-Mb) have a similar estimated size,
analysis indicated that 18.8% (341/1810) and 17.1% (290/1700)
of their protein coding genes are unique (Fig. 1, Table S3 and S4).
Based upon studies by Goris and colleagues [59], the variation we
observe between the C. ureolyticus strains suggests species delinea-
tion, whereby the cut off value for species is 85% conserved genes
(15% unique protein coding genes) for a pair of strains. Such
heterogeneity is likely to result in substantial functional differences
between the two strains both from a general housekeeping and
virulence perspective.
In addition to the high degree of genomic variation observed
between DSMZ 20703 and ACS-301-V-Sch3b strains, protein
profiles of a further 6 C. ureolyticus isolates, whereby strains are
clustered based on their banding patterns (Fig. 2), further confirms
the significant degree of heterogeneity that exists between strains.
A large scale whole genome analysis project including 12 C.
ureolyticus strains, isolated from patients with diarrhoeal illness,
asymptomatic patients and animal reservoirs is currently under
way within our lab. Comparisons of whole genome coding
sequences between these strains support our initial observations of
substantial heterogeneity between C. ureolyticus strains. Paired
genome comparison of the coding genes of 14 C. ureolyticus strains
revealed that 2–20% of their proteins are unique. Furthermore,
individual comparisons of the protein coding genes of the 12 C.
ureolyticus isolates against C. ureolyticus DSM 20703 and C. ureolyticus
ACS-301-Sch-V-3b revealed that 13–19% (average 16%) and 9–
16% (average 12%) of proteins are unique respectively. Such
heterogeneity between the C. ureolyticus type strain and isolates
raises caution regarding its suitability as the type strain for this
species.
Our preliminary data suggest that as with C. concisus, C. ureolyticus
is likely composed of several genomospecies; however, additional
large scale investigations will be required to determine the extent
of genomic variations between strains of different origin and the
consequences that such differences may have on their pathogenesis
and virulence potential (this is the subject of continuing work in
our lab).
The C. ureolyticus secretome
A significant variant in contributing to bacterial pathogenic
potential is the secretome – the totality of secreted proteins -
characterised by its dynamic nature, undergoing variations and
adjustments to match that required by the prevailing environ-
mental conditions [60]. The secretome accounts for a significant
proportion of the total bacterial proteome and is likely to contain a
number of important virulence or virulence associated factors
including colonization and stress survival factors [61]. As such, in
silico based predictions of the C. ureolyticus secretome can assist in
cataloguing the strain’s pathogenic potential.
A total of 288 proteins were predicted to be secreted by C.
ureolyticus DSMZ 20703 (Table S5) including at least 25 proteins
with putative virulence roles (Fig. 3a). Additionally, the secretome
of ACS-265 was predicted to contain 269 proteins (Table S6), 28
of which have proven roles in virulence (Fig. 3b).
Although these results are slightly lower than has been reported
for C. concisus 13826 when using SignalP3.0 [38], our figures align
closely to the predicted secretome of C. jejuni NCTC 11168. A
combination of SignalP4.1 and SecretomeP2.0 analysis, predicted
that a total of 256 proteins (15.5%) were secreted by either classical
or non-classical pathways by C. jejuni NCTC 11168. SignalP4.1
predicted 115 proteins were classically secreted and SecretomeP
predicted 200 proteins were secreted by a signal peptide
Table 3. Comparison of unique and conserved protein coding genes of C. ureolyticus against other Campylobacter species.
C. ureolyticus DSM 20703 C. ureolyticus ACS-301-sch-3b
Comparison Species
Unique Proteins
(%)
Highly Conserved
Proteins (%)
Unique Proteins
(%)
Highly Conserved
Proteins (%)
C. jejuni NCTC 11168 684 (38) 183 (10) 614 (36) 181 (11)
C. jejuni subsp. doylei 269.97 662 (37) 184 (10) 583 (34) 183 (11)
C. coli RM2228 [B] 689 (38) 181 (10) 591 (35) 179 (10.5)
C. lari RM2100 716 (40) 184 (10) 619 (36) 187 (11)
C. upsaliensis RM3195 726 (40) 169 (9) 619 (36) 169 (10)
C. fetus subsp. fetus 82-40 600 (33) 271 (15) 523 (31) 276 (16)
C. curvus 525.92 546 (30) 268 (15) 487 (29) 268 (16)
C. concisus 13826 520 (29) 279 (15) 486 (29) 285 (17)
C. hominis ATCC BAA-381 508 (28) 371 (20) 405 (24) 377 (22)
Average value 628 (35) 232 (13) 574 (32) 234 (14)
doi:10.1371/journal.pone.0071515.t003
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independent manner, however 59 of these proteins overlapped
between the two servers.
These putative secreted virulence factors are of particular
interest in light of a recent report by Burgos-Portugal et al [21],
which showed that the secretome of C. ureolyticus is toxic to host
cells, significantly reducing cell viability in epithelial cell lines. It is
important to note that these proteins are only predicted to be
secreted and remain to be imperially proven.
Genomic variations unique to C. ureolyticus DSMZ 20703;
a virulence perspective
Given that less than 83% of proteins are homologs between the
two C. ureolyticus strains (Table S7 and S8), we identified 341 genes
unique to DSMZ 20703 when compared to ACS-301-V-Sch3b,
encoding proteins with a variety of functions; including capsular
and extracellular polysaccharide formation, iron acquisition,
metabolism, transport systems, phage components, stress response,
16 putative virulence factors subcategorised into toxins and
adhesions, as well as 242 hypothetical proteins (Table S4).
Toxins
We identified 13 haemolytic cytotoxins and cytolysin related
proteins, of which 8 were predicted to be secreted (Table 4).
Owing to their ability to increase the availability of iron during the
process of infection [62], such pore-forming toxins represent an
important component of a pathogen’s virulence repertoire.
Indeed, cell-associated and secreted haemolysins/cytolysins in
the well-studied C. jejuni and several of the emerging Campylobacter
species have previously been noted as potential contributors to
Campylobacter gastroenteritis [62,63].
Within this group, at least 8 repeats-in-toxins (RTX) related
proteins, 6 of which were predicted to be secreted were identified.
Various numbers of such repeats are found in the RTX domains
of several cytotoxins/leukotoxins involved in the virulence of a
number of different Gram-negative genera [64]. A characteristic
feature of these exoproteins is the use of type I secretion systems to
facilitate protein export across the bacterial envelope into the
extracellular space [65]; their functionality being limited by Ca2+
ion availability, which serves to sequester activity until outside of
the bacterial cell [65].
Furthermore, 3 of these secreted RTX haemolysins appear to
be iron-regulated, with homology (up to 52% identity over the
entire amino acid sequence) to the FrpC RTX protein of pathogen
Neisseria Meningitisis. Intriguingly, Osicˇka et al [64], reported the
detection of FrpC-specific antibodies in the sera of patients
recovering from invasive meningococcal disease, demonstrating
that the FrpC-like protein is produced in vivo during infection,
though its exact role in the infectious process remains unknown
Figure 1. DSM 20703 V’s ACS-301-V-Sch3b Synteny Map. Syntenic affinities (conserved blocks) across the whole genome sequences of ACS-
301-V-Sch3b and DSM 20703 were determined using BLAST+ [133]with DSM 20703 used to build the database and using BLASTN to find synteny
within the ACS-301-V-Sch3b genome. The ideogram was built using Circoletto [134] where ribbons represent the local alignments and the colours
blue, green, orange and red, respectively representing the 25% blocks up to the maximum score of 100% and histogram on top of the ideograms,
counting how many times each band has hit the specific part of the sequence.
doi:10.1371/journal.pone.0071515.g001
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[66,67]. Akin to the emerging pathogen C. concisus, the presence of
iron-regulated haemolysins in C. ureolyticus suggests a potential
function for such haemolysins as an important component in
promoting human disease [62].
Additionally, a secreted S-layer RTX protein exhibiting 79%
identity over the entire amino acid sequence of that of C. concisus
was detected. Similarly, a study by Burgos-Portugal [68], which
focused on the secreted proteins of C. ureolyticus UNSWCD,
isolated from an intestinal biopsy of a child with Crohn’s disease,
identified an S-layer RTX protein. Such S-layer proteins are
thought to render resistance to complement while also providing
structures for adherence of the pathogen to the host cell [69]. S-
layer RTX is a pore-forming toxin that is also found in
Campylobacter rectus and toxins within this family are recognized
as true virulence factors [65,70].
Adhesins
Bacterial adhesions are important in establishing initial infec-
tion, permitting host cell interaction and are often a prelude to
later pathological events [71]. Within the group of haemolysins
unique to DSM 20703, two genes encoding the HecA protein, a
member of the filamentous hemagglutinin (FHA) family, were
detected. Furthermore, directly upstream of one of the hecA genes,
the hecB locus, coding for a haemolysin activation protein was also
identified. The HecA/B proteins make up a two-partner secretion
(TPS) system, whereby a TpsA family exoprotein containing a
specific conserved secretion signal is recognised by a TpsB family
channel-forming transporter allowing it to cross the membrane
[72].Rojas and colleagues [73] report that HecA homologs are
found in both animal and plant pathogens and interestingly within
animals appear to be restricted only to pathogenic species.
Furthermore, HecA has been identified as an adhesion contrib-
uting to the virulence of C. jejuni [74].
Interestingly, the 5.8 kb hecA gene within the HecA/B operon
has a G+C content 17% lower than the rest of the C. ureolyticus
genome (G+C content 29%). Given that lateral gene transfer of
hecA genes has previously been noted in other species [75], it is not
unreasonable to suggest that this adhesion may have been
acquired from a pathogen outside the Campylobacter genus.
One possible source of hecA (based on G+C content and signature
codon usage) is the Fusobacterium species; which, similar to C.
ureolyticus [4,19,76], have been linked to periodontitis and
gastrointestinal disease including irritable bowel disease (IBD)
and intermittent colitis [77,78]. It is likely that such genetic
transfer may have occurred when these bacteria occupied the
same ecological niche [79].
Two further adhesions identified in the current study are the
PEB1 homolog and the intracellular multiplication factor protein
IcmF [80,81]. PEB1 is a known colonization and virulence factor
in C. jejuni; with Pei et al [82], reporting that a mutation in the
PEB1 resulted in 50- to 100-fold less adherence to, and 15-fold less
invasion of, epithelial cells in culture. On the other hand, the IcmF
protein, a component of a type VI secretion system (T6SS), has
only recently been identified as playing a role in controlling
bacterial virulence in eukaryotic host cells, along with mediating
competition between bacteria [22,33]. Lertpiriyapong et al [33],
reported that C. jejuni use T6SS to establish persistent colonization.
In addition to IcmF, we have identified homologs of several other
T6SS genes in C. ureolyticus, including 2 ompA/motB genes, inner
membrane proteins responsible for T6SS stabilisation [33]. Given
that T6SS-associated genes appear to be present in emerging
Campylobacter spp. [22], it may be valuable to investigate the
acquisition and potential role of this secretion system in the
pathogenesis of these emerging species.
Finally, a 30 kb region of the DSM 20703 genome contains
genes involved in N-linked gylcosolyation including pglG, pglA, pglB
and pglI, genes coding for flippase enzymes along with those
implicated in exopolysacchaaride and lipopolysaccharide biosyn-
thesis and modification (Table S2). Strikingly within this region,
we have identified genes involved in Sialic Acid (N-acetylneur-
aminic Acid) metabolism. Of particular interest is a cluster of genes
required for de novo synthesis of Sialic Acid; siaC (NeuB
superfamily), siaB (CMP-Neu5Ac-synthase) and siaA (NeuC
superfamily). Furthermore, analysis indicates these genes are
homologous to those of N. meningitidis with 96–100% coverage and
50–76% identity over the entire amino acid sequences. Such genes
are pivotal virulence factors to N. meningitidis, by studding its
capsular polysaccharide and LOS with sialic acid it facilitates their
ability to colonize, persist, evade host immune response and cause
disease in mammalian species [83,84].
Similarily, C. jejuni has three sets of neu genes involved in sialic
acid biosynthesis, whereby it’s thought a complete cluster (neuB1,
C1, A1) has a role in LOS sialylation [85]. Sialic acid is an
uncommon component of bacterial surface structures and,
Figure 2. SDS-PAGE of C. ureolyticus Soluble Proteins. (A) Protein
profiles of 7 Campylobacter ureolyticus strains. Phoretix 1D pro was
employed to cluster the lanes based on banding patterns. The
Dendrogram is an Unweighted Pair Group Method with Arithmetic
Mean (UPGMA) Dice coefficient distance tree. (B) Original SDS-PAGE gel,
with variable regions highlighted. Lane 1: Page Ruler Plus Ladder, lane
2: CIT001, lane 3: CIT002, lane 4: CIT004, lane 5: CIT 005, lane 6: CIT007,
lane 7: CIT009, lane 8: DSM 20703.
doi:10.1371/journal.pone.0071515.g002
Campylobacter ureolyticus Virulence Potential
PLOS ONE | www.plosone.org 7 August 2013 | Volume 8 | Issue 8 | e71515
Figure 3. Bioinformatics based predictions of the C. ureolyticus secretome. (A) 288 proteins were predicted to be secreted by C. ureolyticus
DSMZ 20703 using the SignalP 4.1 server for classically secreted proteins and the SecretomeP 2.0 server for non-classically secreted proteins. Of the
288 proteins, 187 proteins were predicted to be secreted by the SecretomeP 2.0 sever alone, 57 proteins by the SignalP 4.1 alone and 44 proteins
were identified by both servers. Additionally, 117 proteins of 28 were hypothetical, the remaining 171 proteins were associated with a diverse range
of functions relating to membrane transport, protein metabolism, respiration, stress response and at least 25 proteins with putative virulence roles.
(B) SignalP4.1 and SecretomeP2.0 servers predicted 269 proteins are secreted by C. ureolyticus ACS-301-V-Sch3b. 165 proteins were predicted to be
secreted by the SecretomeP 2.0 server alone, a further 65 proteins were identified by the Signal 4.1 server and 39 proteins were identified by both
Campylobacter ureolyticus Virulence Potential
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through molecular mimicry, may be crucial for evasion of host
immunity and in post-infection autoimmune diseases such as
Guillain–Barre´ syndrome [85,86].
Genomic variations unique to C. ureolyticus ACS-301-V-
Sch3b; a virulence perspective
We identified 290 genes unique to ACS-301-V-Sch3b (Table
S3), comprising proteins involved in cell wall and capsule
biosynthesis, membrane transport, phage replication, stress
response, DNA and protein metabolism, 20 putative virulence
factors subcategorised into type IV secretion and toxin-antitoxin
systems as well as 193 hypothetical proteins.
Type IV Secretion systems (T4SS)
We identified 16 genes, 8 of which are predicted to be secreted,
which appear to be involved in the archetypal VirB/D4 Type IV
secretion apparatus (Table 5). Type IV secretion systems (T4SS)
can be regarded as multi-subunit, molecular syringes, spanning the
cell envelope to inject their specific substrate into the cytosol of
target cells [87]. They are involved in conjugative DNA transfer in
prokaryotes [88] and are exploited by several mammalian
pathogens [89] for toxin secretion and targeted delivery of
virulence factors into eukaryotic host cells during infection [90],
contributing directly to pathogenicity [91].
The 16 putative C. ureolyticus virB/D4 genes, appear to contain
all of the necessary components for a structurally functional T4SS.
Additionally, it is worth noting that C. ureolyticus has two copies
each of the virB genes: virB8, virB9, virB10 and virB11. A total of
13/16 and 10/16 of the VirB/D4 proteins in DSM 20703 were
homologs to the virB/D4 genes of C. jejuni and C. fetus subspecies
venerealis with an average Identity of 55% and 60% respectively.
Kienesberger et al [41], reported that mutational inactivation of
the virD4 and virB9 components in virulent C. fetus subsp. venerealis
isolates resulted in attenuated invasion and cell-killing phenotypes
in cultured human cell lines, concluding that the VirB/VirD4
T4SS is necessary for efficient invasion and cytolethal damage
[90,92]. Additionally, C. ureolyticus, like a number of other
pathogens [92], contains a FIC (filamentation induced by cyclic
AMP) domain-containing protein downstream of the virB-virD4
genes. FIC proteins disrupt host cell processes through AMPyla-
tion reactions on target proteins [93], and in C. fetus have been
shown to be potential effector proteins translocated by the T4
machinery to mammalian cell [90], where they regulate host
processes important to pathogen survival and replication [90].
Furthermore, the VirB/D4 genes in pathogen C. jejuni, located
on the pVir plasmid, are likely to play an important role in
bacterial invasion [94,95,96]. In support of this proposal, mutation
analysis of the C. jejuni virB11 gene, carried out by Bacon et al [94],
resulted in a 6-fold reduction in adherence and an 11-fold
reduction in invasion leading to reduced virulence in a ferret
model of infection. Subsequent studies from the same group
reported that modifications to the virB9 gene resulted in a
significant reduction in C. jejuni invasion [95].
Additionally, it is worth noting that the ACS-301-V-Sch3b
strain also contains 3 tra genes; traL, traF and traJ in addition to the
trb operon, composed of at least 10 trb genes; trbB, trbC, trbD, trbE,
trbM, trbJ, trbL,trbF, trbG and trbI. The products of these genes form
part of a F-T4SS [97], however unlike the VirB/D4 genes
associated with the P-T4SS, F-T4SS are most likely concerned
with bacterial conjugation and DNA exchange [91].
Toxin-Antitoxin system
Within the unique proteins of the ACS-301-V-Sch3b strain we
detected a Zeta toxin. This kinase is usually co-expressed as part of
a toxin–antitoxin (TA) module consisting of labile antitoxin
(Epsilon) and a stable toxin (Zeta) in several pathogenic bacteria
[98]. As Zeta toxins may provoke an autolytic phenotype,
Meinhart and colleagues [98], speculate that the suicide of a few
bacteria in a rapidly growing population may promote the release
of other toxins that can attack their host cells or competing
bacteria, thereby protecting their own. On the other hand, Lioy
and colleagues [99], demonstrate that the Zeta toxin initially
induces a set of protective responses, with selective up and down-
regulation of particular genes to promote entry into dormancy
rather than showing bactericidal behaviour. As the ability of TA
systems to induce cell lysis or cell stasis has also been linked to
biofilm and persister cell formation in pathogens [98], it would be
interesting to investigate the prevalence of the Zeta toxin amongst
other C. ureolyticus strains [98,99,100].
Virulence determinants conserved between C. ureolyticus
DSMZ 20703 and ACS-301-V-Sch3b
Amongst the 1,469 homologous proteins (Tables S5 and S6)
shared between these two strains include a minimum of 35
putative virulence factors (Table 4 and 5) associated with motility
and biofilm formation, adhesion and invasion.
Type IV pili (TFP): twitching motility
Bacterial motility is an important factor in survival and
pathogenesis [101]; however unlike most other Campylobacter
species C. ureolyticus employs a flagellum-independent motility with
the aid of type IV pili (TFP) [102,103,104]. At least 10 proteins
associated with the formation of TFP were identified in both
strains (Table 4 and 5). TFP are thin, flexible fibres displayed by a
wide variety of Gram-negative bacteria whereby they use a
modified version of the type II secretion system for their
biogenesis. Such bacteria may employ TFP as linear actuators to
enable directional crawling known as ‘‘twitching’’ motility, bearing
resemblance to a grappling hook [6,105,106,107,108]. To
negotiate significantly long distances (several microns) and
orientate direction [100], multiple type-IV pili undergo cycles of
repeated extension-adhesion and retraction-release using a ‘‘tug-
of-war’’ mechanism [108,109] driven by an ATP motor [110].
TFPs are known bacterial virulence factors supporting adhesion to
host cells and abiotic surfaces, biofilm formation, motility, and
horizontal gene transfer [105,111,112].
Adhesion and Invasion
Amongst common features of many pathogenic microorganisms
is their ability to utilize host cell factors to facilitate attachment and
invasion. Of particular interest in the C. ureolyticus genome are 3
fibronectin associated proteins, 2 of which, Campylobacter adhesion
to fibronectin (CadF) and Fibronectin-like protein A (FlpA), are
predicted to be secreted. Fibronectin, a large glycoprotein, is a
component of the extracellular matrix (ECM) of the human
intestinal epithelium, serving as an adhesion molecule for many
bacteria pathogens [113]. The CadF and FlpA proteins are
servers. Of the 269 secreted proteins, a total of 94 were hypothetical proteins, the remaining 175 proteins were predicted to have a wide range of
functions including DNA metabolism, cell wall synthesis, sulphur and nitrogen metabolism and at least 28 proteins with putative virulence roles.
doi:10.1371/journal.pone.0071515.g003
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Table 4. Putative virulence associated genes in C. ureolyticus DSM 20703.
Gene Function Accession No.
Homolog in
ACS-301-V-Sch3b Secreted
Type IV pili (T4P) Formation
Twitching motility protein PilT KC907219 Yes No
Type II secretion envelope pseudopilin protein (PulG,guides folded protein
to PulD in outer membrane)
KC907220 Yes No
Type II secretion envelope pseudopilin protein (PulG,guides folded protein
to PulD in outer membrane)
KC907221 Yes No
Type IV pilus biogenesis protein PilQ KC907222 Yes No
Type IV pilus biogenesis protein PilQ KC907223 Yes No
Type IV pilus biogenesis protein PilQ KC907224 Yes Yes
Leader peptidase (Prepilin peptidase)/N-methyltransferase KC907225 Yes No
Type II secretory pathway, ATPase PulE/Tfp pilus assembly pathway,
ATPase PilB
KC907226 Yes No
putative prepilin-type N- cleavage/methylation domain protein KC907227 Yes Yes
Type II secretion envelope pseudopilin protein (PulG,guides folded protein
to PulD in outer membrane)
KC907228 Yes Yes
Twitching motility protein PilT KC907229 Yes No
Factors involved in colonisation and adhesion
Autotransporter adhesin with YadA-like domain KC907230 Yes Yes
exoprotein with autotransporter precursor KC907231 Yes Yes
FlpA; Type III fibronectin domain-containing lipoprotein KC907232 Yes Yes
Fibronectin/fibrinogen-binding protein KC907233 Yes No
CadF; Outer membrane fibronectin-binding protein KC907234 Yes Yes
Death-on-curing family protein KC907235 Yes No
Death-on-curing family protein KC907236 Yes No
(HecA) Filamentous Hematagluttinin/Putative large exoprotein involved
in heme utilization or adhesion
KC907237 No No
(HecA) homolog Filamentous Hematagluttinin/Putative large exoprotein ,
heme utilization or adhesion
KC907238 No No
Two-component system response regulator RacR KC907239 Yes No
Major outer membrane protein (Cmp/PorA) KC907240 Yes Yes
PAL; Peptidoglycan associated lipoprotein Omp 18 KC907241 Yes Yes
CjaC homolog KC907242 Yes Yes
Amino acid ABC Transporter/PEB1 (surface antigen) homolog KC907243 No Yes
Outer membrane lipoprotein omp18 precursor/CjaD KC907244 Yes Yes
Capsule biosynthesis protein capA KC907245 Yes No
CjaA surface adhesion KC907246 Yes Yes
PEB4; Major antigenic peptide KC907247 Yes Yes
Hemolysins
Putative hemolysin KC907248 Yes No
Probable hemagglutinin/S-type Pyocin/Colicin E3 (cytotoxic domain) KC907249 No Yes
TlyC; Hemolysins and related proteins containing CBS domains KC907250 Yes No
TlyC; Hemolysins and related proteins containing CBS domains KC907251 Yes No
Channel-forming transporter/hemolysin activation protein (HecB) TVSS KC907252 No No
Filamentous haemagglutinin family; VacA-like (serine protease) KC907253 No Yes
RTX related cytotoxins
RTX haemagglutinin, iron-regulated protein FrpC (N. meningitidis) related
to hly
KC907254 No Yes
RTX haemagglutinin, iron-regulated protein FrpC (N. Meninfitidis) related
to hly
KC907255 No Yes
RTX-Hemolysin-type calcium-binding region:FrpC related KC907256 No Yes
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reported as major virulence factors in C. jejuni and facilitate
adhesion and colonization to host epithelial cells [113,114].
Interestingly, a functional analysis of the C. ureolyticus secretome
led Burgos-Portugal et al [21], to report the presence of a ‘CadF
homologue’ which they suggest to be a significant contributing
factor to the pathogenic potential of C. ureolyticus UNSWCD,
presumably allowing for adhesion to and subsequent colonization
of host cells.
Furthermore, CadF and FlpA have also been reported to be
involved in the activation of the small Rho GTPases Rac1 and
Cdc42 (by an as yet uncharacterised mechanism), enabling host
cell entry [30,115]. The fibronectin host cell-surface receptor is the
a5b1 integrin which is located on the luminal surface of M cells in
the gastrointestinal tract and may promote preferential binding
[116]. However, in intact epithelia, this is restricted to the
basolateral surface and as such is not readily available for
interaction with luminally positioned microbial pathogens
[117,118]. Monteville et al. [119] demonstrated that adherence
and internalization of C. jejuni were significantly increased by
exposure of cellular basolateral surfaces, and that Fn was the
receptor; suggesting that C. jejuni invasion may preferentially occur
via a paracellular rather than an intracellular route.
Intriguingly, in vitro studies of C. ureolyticus UNSWCD indicate
that this organism is capable of translocating across the cell
monolayer, proposing that, as with C. jejuni, C. ureolyticus might also
invade via a paracellular route [21]. In support of this hypothesis,
in addition to the fibronectin binding proteins, we have also
identified the zona occludins toxin (Zot) in both C. ureolyticus
strains. The apical domain of epithelial cells is separated from the
lateral domain by the zonula occludens, which forms the tight
junction [120]. Zot is known to mimic a physiological modulator
of intercellular tight junctions, and is used by virulent pathogens
such as Vibrio cholerae and Neisseria meningitidis to induce a reversible
opening of tight junctions between cells and increase the
paracellular permeability in a non-toxic manner [121,122].
Analysis indicates that Zot of C. ureolyticus bears greatest
resemblance to that of C. concisus (Fig. 4), forming paraphyletic
groups and thus are likely to have shared a common ancestor. As
proposed for the emerging pathogen C. concius [5] and in
agreement with in vitro studies [21], it is likely that C. ureolyticus is
capable of attaching to and invading the host paracellularly. We
suggest C. ureolyticus likely targets the host cell tight junctions, by
expressing Zot, and binds to the basolateral surface of the cell via
fibronectin binding proteins such as the secreted CadF and FlpA.
Additional factors which may promote C. ureolyticus adhesion,
colonisation and invasion include the 4 secreted proteins CjaA,
CjaC, PEB4 and Pal/Omp18. The CjaA, CjaC and Pal/Omp18
represent a surface-exposed protein, an ABC-transporter protein
and a cell membrane-associated protein respectively. All 3 proteins
are known to be highly immunogenic during human infection with
the foodborne pathogen C. jejuni [123]. Moreover, the PEB4
protein is an antigenic virulence factor implicated in host cell
adhesion, invasion, and colonization in C. jejuni [100].
Table 4. Cont.
Gene Function Accession No.
Homolog in
ACS-301-V-Sch3b Secreted
RTX related Ca binding hemolysin (FrpC homolog)outer membrane
adhesin-like protein, partial
KC907257 No Yes
Calcium binding hemolysin protein (Not in other Campy spp)/LeukotoxinA
(lktA)/hlyA
KC907258 No No
Haemolysin type calcium binding protein RTX related KC907259 No Yes
Toxins
Vacuolating cytotoxin paralog VacA KC907260 Yes Yes
Addiction module toxin, RelE/StbE family KC907261 Yes No
Zona occludens toxin KC907262 Yes No
Zona occludens toxin KC907263 Yes No
S-layer RTX protein KC907264 No Yes
Invasion
Campylobacter invasion antigen B (CiaB) KC907265 Yes No
PldA; Phospholipase A1 precursor; Outer membrane phospholipase A KC907266 Yes Yes
U32 Pepsidase; collagenase family KC907267 Yes No
Cell wall-associated hydrolases (invasion-associated proteins) KC907268 Yes Yes
T6SS
IcmF-related protein KC907269 No No
Type II secretion system
MSHA biogenesis protein MshL KC907270 Yes Yes
MSHA biogenesis protein MshM KC907271 Yes No
Type I Secretion system
Type I secretion membrane fusion protein, HlyD/LktD (Hemolysin secretion
protein)
KC907272 No No
Hemolysin secretion protein HlyB/Leukotoxin translocation; LktB KC907273 No No
doi:10.1371/journal.pone.0071515.t004
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Table 5. Putative virulence associated genes in C. ureolyticus ACS-301-V-Sch.
Gene Function Accession No.
Homolog in
DSM 20703 Secreted
Type IV secretion system (T4SS)
Minor pilin of type IV secretion complex (VirB5) KC465892 No Yes
Inner membrane protein forms channel for type IV secretion of T-DNA complex, VirB4 KC465888 No No
ATPase provides energy for assembly of type IV secretion complex& secretion of T-DNA
complex (VirB11)
KC465883 No No
Type IV secretion/competence protein (VirB10) KC465893 No Yes
Type IV secretion/competence protein (VirB9) KC465894 No Yes
VirB8 KC465897 No No
VirB4 KC465896 No No
Bores hole in peptidoglycan layer allowing type IV secretion complex assembly to
occur (VirB1)
KC465885 No Yes
Type IV secretion system protein VirD4 KC465895 No No
Integral inner membrane protein of type IV secretion complex (VirB6) KC465891 No Yes
Inner membrane protein forms channel for type IV secretion of T-DNA complex, VirB8 KC465890 No No
Forms the bulk of type IV secretion complex that spans outer membrane and periplasm
(VirB9)
KC465887 No No
Inner membrane protein forms channel for type IV secretion of T-DNA complex (VirB10) KC465889 No Yes
ATPase required for both assembly of type IV secretion complex and secretion of T-DNA
complex, VirB11
KC465884 No No
Coupling protein VirD4, ATPase required for T-DNA transfer KC465886 No No
IncQ plasmid conjugative transfer DNA nicking endonuclease TraR (pTi VirD2 homolog) KC907204 No Yes
Type IV sectreion/conjugative transfer protein TrbC (VirB2; pilins) KC907205 No Yes
Adhesion and colonisation
Death-on-curing family protein KC465877 Yes No
Death on curing protein, Doc toxin KC465876 Yes No
Cell filamentation-like protein (Fic domain) KC465874 No No
Cell Surface Protein (YadA Domain protein) KC465875 Yes Yes
CadF; Outer membrane fibronectin-binding protein KC465879 Yes Yes
Fibronectin/fibrinogen-binding protein KC465878 Yes No
FlpA; Type III fibronectin domain-containing lipoprotein (String) KC465881 Yes Yes
Two-component system response regulator RacR KC465882 Yes No
Outer membrane lipoprotein omp18 precursor/CjaD KC907206 Yes Yes
Capsule biosynthesis protein capA KC465850 Yes No
CjaA; surface antigen KC907207 Yes Yes
CjaC KC907208 Yes Yes
PEB4; Major antigenic peptide KC907209 Yes Yes
Major outer membrane protein (Cmp/PorA) KC907210 Yes Yes
PAL; Peptidoglycan associated lipoprotein Omp 18 KC907211 Yes Yes
Invasion and intracellular resistance
Campylobacter invasion antigen B (CiaB) KC465873 Yes No
Cell wall-associated hydrolases (invasion-associated proteins) KC907212 Yes Yes
PldA; Phospholipase A1 precursor; Outer membrane phospholipase A KC465880 Yes Yes
U32 pepsidase; collagenase family KC465849 Yes No
Toxins
Putative vacuolating cytotoxin (VacA) paralog KC465870 Yes Yes
Zona occludens toxin KC465872 Yes No
Zeta toxin KC465871 No Yes
Hypothetical protein; addiction module RelE/StbEtoxin KC465869 Yes No
MSHA biogenesis protein MshL pilus (Type ii and iii secretion system) KC907213 Yes Yes
MSHA biogenesis protein MshM KC907214 Yes No
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A further two proteins, the Campylobacter invasive antigen
(CiaB) and the secreted phospholipase A (PldA), were detected and
are likely to contribute to the pathogenic potential of C. ureolyticus.
PCR confirmed that the ciaB gene is common among C. ureolyticus
strains (Fig. S1) and ClustalW alignment revealed that the
nucleotide sequence of this gene is highly conserved between
strains. Both CiaB and PldA have been linked to an invasive
phenotype in C. jejuni [124]. Indeed, disruption of the C. jejuni ciaB
gene, which encodes a protein that is translocated into the
cytoplasm of eukaryotic cells, results in a non-invasive phenotype
[125].
Autotransporters
A protein family of particular interest, predicted to be present in
both C. ureolyticus strains, are the autotransporters. These proteins
represent an extensive and rapidly growing family contributing to
bacterial virulence in Gram-negative bacteria such as C. jejuni and
H. pylori [126,127]. Although autotransporters share a common
mode of secretion (similar translocation units), the passenger
domains at the N-termal of the protein are highly diverse [128].
Almost without exception, all characterized passenger protein
domains of autotransporters have been implicated in bacterial
virulence relating to bacterial motility, adhesion, host immuno-
modulation, toxigenicity and intracellular spread [127,128].
Table 5. Cont.
Gene Function Accession No.
Homolog in
DSM 20703 Secreted
Hemolysins and Haemagluttinins
Putative hemolysin KC465868 Yes No
Hemolysins and related proteins containing CBS domains (TlyC) KC465866 Yes No
Hemolysins and related proteins containing CBS domains (TlyC) KC465867 Yes No
Hemagluttinin/autotransporter KC907215 No Yes
Hemagluttinin/autotransporter KC907216 Yes Yes
Type IV pili
Type II secretory pathway, ATPase PulE/Tfp pilus assembly pathway, ATPase PilB KC465857 Yes No
Type IV pilus biogenesis protein PilQ KC465858 Yes No
Leader peptidase (Prepilin peptidase)/N-methyltransferase KC465851 Yes No
Putative prepilin-type N- cleavage/methylation domain protein KC465854 Yes Yes
Twitching motility protein PilT KC465855 Yes No
Twitching motility protein PilT KC465856 Yes No
Type II secretion envelope pseudopilin protein (PulG) KC907217 Yes No
Type II secretion envelope pseudopilin protein (PulG) KC907218 Yes No
doi:10.1371/journal.pone.0071515.t005
Figure 4. Evolutionary relationships of taxa Zona Occluden Toxin (ZOT). The evolutionary history was inferred using the Neighbor-Joining
method. The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (1000 replicates) is shown next to the
branches. The tree is drawn to scale, with branch lengths in the same units as those of the evolutionary distances used to infer the phylogenetic tree.
DSMZ 1 and DSMZ 2 correspond to the ZOT paralogs in C. ureolyticus DSM20703. ACS-301-V-Sch-3b:C. ureolyticus ACS-301-V-Sch-3b.
doi:10.1371/journal.pone.0071515.g004
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Although we have identified several autotransporter related
genes (Table 4 and 5), the products of which have all been
predicted to be secreted, of particular interest were the adhesion
related autotransporters (2 copies of which are found in ACS-301-
V-Sch3b) containing a YadA domain. The YadA protein is a
major adhesin of Yersinia pseudotuberculosis which is noted to
promote tight adhesion to mammalian cells by binding to
extracellular matrix proteins [108]. Eitel et al. [108] reports the
expression of YadA promotes both bacterial adhesion and high-
efficiency invasion. Moreover, the YadA protein has been detailed
to mediate the initial adhesion, uptake, and transfer of the bacteria
through M cells of the intestine in addition to establishing
extracellular colonization of the liver, spleen and underlying
lymphatic tissue [108].
Toxin-Antitoxin systems
Interestingly, two bacterial toxin–antitoxin (TA) systems RelE/
StbE and the death on-curing (Doc) toxin were conserved in both
C. ureolyticus strains. TA modules are highly abundant in
opportunistic pathogens such as Mycobacterium tuberculosis, as
mentioned previously when discussing the Zeta toxin, the ability
of TA systems to induce cell lysis or cell stasis has been linked to
biofilm and persister cell formation in pathogens [98,129]. RelE
for example, is a global inhibitor of translation during nutrient
stress, and its expression reduces the chance of starvation by
lowering the cell’s nutrient requirements [130]. Doc, which
appears to be quite conserved amongst strains as indicated by
PCR (Fig. S1) and expressed under standard conditions, resembles
members of another family of bacterial proteins called Fic.
Bacterial toxin–antitoxin (TA) systems typically facilitate cell
survival during intervals of stress allowing cells to switch to a
reversible quasidormant state [131] and expression of such genes
under standard conditions may be reflective of a subset of older or
stressed cells in the culture. It is likely that these systems may be of
particular importance relating to the viable but non-cultivable
(VBNC) phenomenon observed within several Campylobacter species
[15,132].
Conclusion
The pathogenic mechanisms responsible for acute intestinal
infections by Campylobacter spp, although still poorly understood,
are thought to involve adherence, cellular invasion, and toxin
production. With the aid of whole genome analysis, comparative
bioinformatics and secretome prediction we have identified a
minimum of 106 potential virulence related factors, encompassing
each of the known virulence tactics of pathogenic Campylobacter
spp. Furthermore, similar to the emerging pathogen C. concisus,
using genome comparisons and proteins profiles we propose the
possibility of genomospecies within C. ureolyticus; a taxonomic
continuum comprised of several species that are likely to have
different impacts on human health and disease. Campylobacter
species tend to be specialists not generalists, thus the presence of
such a diverse number of virulence homologs warrants functional
investigation. This study provides the first whole genome analysis
of C. ureolyticus and a catalogue for the investigation and
confirmation of this pathogen’s virulence gene arsenal.
Supporting Information
Figure S1 PCR analyses of the RTX 2861 bp (A), VirD4
1,625 bp (B), CiaB 1469 bp (C) and Doc 311 bp (D) genes in seven
Campylobacter ureolyticus strains. Lane 1: Molecular weight marker
Hyperladder I (A–C), Hyperladder II (D), lane 2: CIT01, lane 3:
CIT02, lane 4: CIT04, lane 5: CIT 05, lane 6: CIT07, lane 7:
CIT09, lane 8: DSM 20703 and lane 9: negative control. It is
important to note that the absence of an amplicon does not
confirm the absence of the gene. The primers are specific to the
nucleotide sequences of C. ureolyticus DSM 20703 and/or C.
ureolyticus ACS-301-V-Sch3b and does not account for single
nucleotide polymorphisms or variable regions between strains
within the primer annealing regions. This PCR should be seen as a
confirmatory rather than exclusionary test. Also, rt-PCR indicated
that of theses 4 genes, doc was the only protein expressed under
standard conditions (in all 5 strains as above).
(TIF)
Table S1 Sequence based comparison: 128 protein coding genes
of C. ureolyticus DSM 20703 and ACS-301-V-Sch3b highly
conserved (.70% amino acid identity) across 8 different
Campylobacter species and 1 subsp.
(XLSX)
Table S2 Sequence based comparison: 65 protein coding genes
of C. ureolyticus DSM 20703 and ACS-301-V-Sch3b highly
conserved within these strains (.70% amino acid identity) but
no homologs (,25% amino acid identity) within 8 different
Campylobacter species and 1 subspecies.
(XLSX)
Table S3 Sequence based comparison: 341 genes out of 1810
genes in C. ureolyticus DSM 20703 with below 25% identity in
comparison to C. ureolyticus ACS-301-V-Sch3b.
(XLSX)
Table S4 Sequence based comparison: 290 genes out of 1700
genes in C. ureolyticus ACS-301-V-Sch3b with below 25% identity
in comparison to C. ureolyticus DSM 20703.
(XLSX)
Table S5 Secretome of C. ureolyticus DSM 20703.
(XLSX)
Table S6 Secretome of C. ureolyticus ACS-301-V-Sch3b.
(XLSX)
Table S7 Sequence based comparison: 1469 out of 1810 genes
in C. ureolyticus DSM 20703 and 1700 genes in C. ureolyticus ACS-
301-V-Sch3b with greater than 25% identity.
(XLSX)
Table S8 Sequence based comparison: 1410 genes out of 1700
genes in C. ureolyticus ACS-301-V-Sch3b and 1810 genes C.
ureolyticus DSM 20703 with greater than 25% identity.
(XLSX)
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